# the Effective Bolus Dose of Remifentanil for Laryngeal Mask Airway (LMA) Insertion in Children

> **NCT01919203** · NA · COMPLETED · sponsor: **Sangjin Park** · enrollment: 50 (actual)

## Conditions studied

- Respiratory Complication

## Interventions

- **DRUG:** Remifentanil

## Key facts

- **NCT ID:** NCT01919203
- **Lead sponsor:** Sangjin Park
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-08
- **Primary completion:** 2015-07
- **Final completion:** 2015-07
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2015-07-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01919203

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01919203, "the Effective Bolus Dose of Remifentanil for Laryngeal Mask Airway (LMA) Insertion in Children". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01919203. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*